All B&C® News

January 17, 2018
Richard E. Engler, Ph.D., Quoted by NBC News Regarding Changes to EPA’s New Chemical Assessments
On January 17, 2018, Richard E. Engler, Ph.D., Senior Chemist at Bergeson & Campbell, P.C. (B&C®), was quoted by NBC News in the article “EPA eases path for new chemicals, raising fears of health hazards.” The EPA’s new approach is likely to reduce the testing that manufacturers who first bring these new chemicals to market are required to do. Using significant new-use rules (SNURs) “reduces the testing that the EPA is seeking to impose, because testing is rarely required in a SNUR,” said Richard Engler, a former EPA scientist ... read more >
January 10, 2018
Bloomberg BNA Daily Environment Report References NCC Response in “Environmentalists Challenge Safety of EPA's New Chemical Reviews”
On January 10, 2018, the Bloomberg BNA Daily Environment Report covered the TSCA New Chemicals Coalition’s (NCC) response to a federal court challenge by the Natural Resources Defense Council (NRDC) against the U.S. Environmental Protection Agency's (EPA) New Chemicals Decision-Making Framework. The New Chemicals Coalition, which Bergeson & Campbell P.C. launched in 2017 as a forum for companies interested in bringing new chemicals to market, has not decided whether or not it will intervene. The firm will continue to track the case, Lynn Bergeson, managing partner ... read more >
January 4, 2018
TSCAblog™ Post Quoted in “Fluoride Case Ruling May Open Door To More TSCA Petitions, Attorneys Say”
On January 4, 2018, the TSCAblog™ post “In Case of First Impression, Court Rules EPA Wrongly Dismissed Citizen Group’s TSCA Section 21 Petition” was quoted by Inside EPA in an article discussing the U.S. Environmental Protection Agency’s (EPA) Toxic Substances Control Act (TSCA) Section 21 ruling on flouride.  The law firm Bergeson & Campbell describes the ruling as a “fairly scathing rebuke of EPA’s legal positions,” in a Dec. 22 blog post, adding that it “essentially rejected EPA’s interpretation that a citizen petition ... read more >
December 29, 2017
Chemicals Northwest Winter Elements Magazine Features Acta as Industry’s “One-Stop Solution” for Global or Local Chemical Regulatory Compliance
The Acta Group (Acta®) was featured in the Winter 2017 Elements Magazine, published quarterly by Chemicals Northwest as a “one-stop solution” for global or local chemical regulatory compliance, especially for companies preparing for the May 13, 2018 Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) deadline. Acta has frequently received recognition from clients and industry globally for our previous and ongoing demonstrations of excellence, most recently receiving the Supply Chains Award at the Chemicals Northwest Awards, hosted at Crowne Plaza ... read more >
December 19, 2017
Michael S. Wenk, M.S., Quoted in Bloomberg BNA Daily Environment Report Article “Australia, EU, Brazil Making Moves in 2018 on Chemical Regulation”
On December 19, 2017,  Bloomberg BNA Daily Environment Report included comments by Michael S. Wenk, M.S., Senior Regulatory Consultant with Bergeson & Campbell, P.C. (B&C®), regarding future chemical regulations in Brazil. Big questions remain, among them: Will Brazil recognize industrial chemicals registered through other systems like the Toxic Substances Control Act in the U.S., or REACH in the European Union? Or will companies have to reproduce testing results? Even when the draft eventually emerges from the revision process and those questions are presumably answered, ... read more >
December 18, 2017
Bloomberg BNA Daily Environment Report Includes Comments by Lynn L. Bergeson Regarding FDA Draft Guidance for Nanomaterial Drugs
On December 18, 2017, Lynn L. Bergeson, Managing Partner of Bergeson & Campbell, P.C. (B&C®), was quoted by the Bloomberg BNA Daily Environment Report in the article “FDA Pushes Risk-Based Approach to Nanomaterial Drugs.” Developers of drugs containing nanomaterials—substances so small they can't be seen with a regular microscope—got some advice on how to assess their risks in FDA draft guidance issued Dec. 15. […] Without having read it in detail yet, Lynn Bergeson, managing partner of Bergeson & Campbell PC, told Bloomberg BNA in a Nov. ... read more >
December 15, 2017
Chemical Watch Quotes the TSCA New Chemicals Coalition in “Industry group: US EPA should cede workplace hazard regulation to Osha”
On December 15, 2017, Chemical Watch featured comments by the TSCA New Chemicals Coalition (NCC) on the U.S. Environmental Protection Agency’s (EPA) new chemical evaluation policy. An industry group has argued that the US EPA should avoid issuing orders to mitigate workplace risks associated with new chemicals. Instead, it says, it should turn over that regulatory responsibility to the Occupational Health and Safety Administration (Osha). The TSCA New Chemicals Coalition (NCC), a group of companies represented by the law firm Bergeson & Campbell, hopes to build on a provision in ... read more >
December 11, 2017
Richard E. Engler, Ph.D., Quoted in Chemical Watch “OPPT director defends US agency plans for new chemical evaluation”
On December 11, 2017, Richard E. Engler, Ph.D., Senior Chemist at Bergeson & Campbell, P.C. (B&C®), was quoted in Chemical Watch regarding concerns with the U.S. Environmental Protection Agency’s (EPA) plan to move away from consent orders in favor of Significant New Use Rules (SNURs) when regulating potential uses of new chemicals. When the situation described in a pre-manufacture notice (PMN) is not of concern, but there is a potential use of the new chemical that would raise risk concerns, the EPA used to issue consent orders restricting how it can be used, followed by ... read more >
December 11, 2017
Comments by Lynn L. Bergeson Regarding TSCA Implementation under the Trump Administration Featured in Chemical Week
On December 11, 2017, Lynn L. Bergeson, Managing Partner of Bergeson & Campbell, P.C. (B&C®), was quoted in the Chemical Week article “Trump's EPA: TSCA remains priority amid regulatory rollback.” “Not surprisingly, there’s been a tremendous focus on the implementation requirements for Lautenberg,” says Lynn Bergeson, managing partner of Bergeson & Campbell (Washington, DC). Efforts have included building a conceptual framework of how to review and apply the new standards under key sections that cover manufacturing and process notices; how ... read more >
December 8, 2017
Scott J. Burya, Ph.D. Joins The Acta Group and Bergeson & Campbell, P.C.
The Acta Group (Acta®) and Bergeson & Campbell, P.C. (B&C®) are pleased to announce that Scott J. Burya, Ph.D. has joined our firms as a Regulatory Chemist.  Dr. Burya holds a Ph.D. in analytical chemistry from the Ohio State University and will support clients in all stages of product development, from assessing the toxicology and regulatory profiles of new substances, performing quantitative risk assessments, and navigating state and federal regulations, to guiding teams through complex submission processes.  His areas of expertise include the Toxic Substances ... read more >
 < 1 2 3 4 5 >  Last › View 10 | 25 | 50 | 100 per page
2200 Pennsylvania Ave, N.W. Suite 100W
Washington, D.C. 20037
(202) 557-3800 • (202) 557-3836 (fax) |
Contact • Twitter
Privacy and Terms of Use | Attorney Advertising | Trademarks
©2018 Bergeson & Campbell, P.C.
All Rights Reserved.